Advanced Biomedical Engineering
Online ISSN : 2187-5219
Operator Safety Zone During the Nitric Oxide Inhalation Vasoreactivity Test for Pulmonary Hypertension Patients
Kanae HashimotoAkiyoshi HashimotoMasumi KishimotoKosuke SugawaraHitomi FunahashiKota NakanoHirohito TakahashiSyuichi HashimotoTetsuji MiuraKazufumi Tsuchihashi
Author information
JOURNALS FREE ACCESS

Volume 6 (2017) Pages 88-94

Details
Download PDF (3217K) Contact us
Abstract

Background and Objective: Acute vasoreactivity testing using inhaled nitric oxide (NO) is performed to determine the treatment strategy in patients with pulmonary hypertension. Operators of the test are exposed to NO and nitrogen dioxide (NO2) to the same extent during the test procedure, but the safety zone for operators in the catheterization laboratory is unclear. This study aimed to clarify the safety zone for operators during the NO inhalation test. Methods: The mask was placed on the examination table in the catheterization laboratory. NO was added using the INOvent® (INO-Therapeutics, LLC), which was attached to an oxygen line and delivered NO to the mask. During simulated NO inhalation tests (n = 10) in a catheterization laboratory, NO and NO2 concentrations were measured at nine specified locations: at the mask outflow port (E0); 25 cm (E25) and 50 cm (E50) from the mask outflow port; heights of 25 cm (A25) and 50 cm (A50) above E0 and E25; and a height of 25 cm (B25) below E0 and E25. During NO inhalation testing conducted in 5 patients, concentrations of NO and NO2 were measured at E0 and E25A50. The Steel-Dwass and Student t-tests were used to perform intergroup analyses. Results: NO-E0A25 (0.00 ± 0.00 ppm), NO-E25A25 (0.01 ± 0.10 ppm), NO-E0A50 (0.00 ± 0.00 ppm), and NO-E25A50 (0.00 ± 0.00 ppm) were significantly lower than NO-E0 (17.01 ± 0.22 ppm), NO-E25 (4.06 ± 0.47 ppm), and NO-E50 (1.90 ± 0.39 ppm) (p < 0.01, all comparisons). NO2 concentrations were less than 0.1 ppm at all nine locations. NO and NO2 concentrations were not affected by room temperature (20, 24, or 28℃) or the flow rate of oxygen (15 or 10 L/min). During NO inhalation testing in patients, NO-E25A50 (0.20 ± 0.45 ppm) was significantly lower than NO-E0 (7.20 ± 2.39 ppm, p < 0.01); however, no significant difference in the NO2 concentration was seen between NO2-E0 (0.220 ± 0.179 ppm) and NO2-E25A50 (0.180 ± 0.205 ppm). Conclusions: An operator safety zone in NO vasoreactivity testing is a zone >25 cm in all directions from the mask for NO inhalation. The concentrations of NO and NO2 to which an operator is exposed in the clinical setting are within the permissible exposure limits defined by the National Institute for Occupational Safety and Health.

Information related to the author
© 2017 Japanese Society for Medical and Biological Engineering
Previous article Next article

Recently visited articles
feedback
Top